news.cision.com

Cantargia AB (publ) today announce that the first patient in the phase IIa part of the CANFOUR clinical trial has received CAN04 (nidanilimab) treatment in accordance with the clinical protocol. The CANFOUR trial investigates the antibody CAN04 for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. CAN04 is targeted against interleukin 1 receptor accessory protein (IL1RAP) and is studied both as single agent therapy as well as in combination with standard first line chemotherapy in NSCLC and pancreatic cancer, respectively.Cantargia is developing the antibody CAN04

HOK-Elanto is concentrating its operations in Tripla in Pasila, Helsinki

YIT Corporation Press release 25 January 2019 at 9:30 a.m.The newest operator moving into Tripla’s Workery offices in Helsinki, Finland, is HOK-Elanto, the biggest regional cooperative of the S Group. The new lease agreement brings the occupancy rate of Tripla’s office spaces up to about 80 percent. HOK-Elanto is concentrating services and operations in the Tripla complex being built in Pasila, Helsinki. In the shopping centre called Mall of Tripla, HOK-Elanto will have stores of Prisma, Alepa and Emotion as well as three new restaurant concepts. In addition, S Group will open a new

ChromoGenics AB is launching world’s most transparent electrochromic glass

The ConverLight75 glass has a light transmission over 75% in the light stage and used in an insulated glass unit it blocks more than 80% of the heat from the sunlight. The unique colour neutrality gives ConverLight75 an increased aesthetic impression requested by architects and a minimal distortion of the colours in the room.Nobody has missed how important daylight and outside view is for our health and well-being. Research shows1 that access to natural daylight and outside view leads to better performance, less tiredness, lessens eyestrain and headache. Also, the coloration of the light

NeuroVive’s Board Members, Senior Executives and employees have subscribed to shares in the ongoing rights issue

In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at least 1,778,995 shares equivalent to MSEK 2.4 which exceeds current holdings.The subscription period in the current rights issue in NeuroVive is ongoing until February 6, 2019 and is open to both existing and new investors. Read more about the rights issue at neurovive.emissioner.se. Prospectus (in Swedish), containing full terms and conditions, as well as application forms are available on NeuroVive's website www.neurovive.com, Stockholm Corporate Finance AB's

Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims

Fri, Jan 25, 2019 08:18 CET

Press release 25 January 2019 Results from German multicentre study strengthen and broaden ColdZyme's product claims At the Icelandic Medical Association conference in Reykjavik on 24 January Enzymatica presented the final results from the German multicentre study for assessment of ColdZyme® Mouth Spray during the 2018 cold season. The convincing results strengthen and broaden ColdZyme's product claims. The location was chosen because the enzyme used in ColdZyme was discovered and patented in Iceland, where it is now also extracted and produced. The statistically significant

Nordic Nanovector ASA - Key information regarding intentional repair offering

Reference is made to the announcement by Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company") on 25 January 2019 concerning a private placement with gross proceeds in the amount of approximately NOK 222 million and a contemplated repair issue of up to 777,777 new shares (the "Repair Offering") with non-tradeable subscription rights to eligible shareholders. Date for announcement of terms: 25 January 2019 Last day including right to receive subscription rights: 24 January 2019 First day excluding right to receive subscription rights: 25 January 2019 Record

VibroSense transforms the future of healthcare with Medtronic

Fri, Jan 25, 2019 08:10 CET

On 28 and 29 November 2018, the European Innovation Council (EIC) and Medtronic, a leader in the world of medical technology, gathered 20 companies to discuss the transformation of healthcare and promote business partnerships. VibroSense shared its solutions for early detection and diagnosis of nerve injuries in hand and foot (peripheral sensory neuropathy) caused by diabetes or by chemotherapy treatment of cancer.Small and medium enterprises (SMEs) have been playing an increasingly crucial role in the development of new products in the medical device industry. Quick adaptability, the

Insplorion prolongs the maturity period and the period for conversion into shares of the convertible debentures in series KV1 2018/2019

Fri, Jan 25, 2019 08:07 CET

On 24 January 2019 the board of directors of Insplorion resolved to prolong the maturity period and the period for conversion into shares of convertible debentures of series KV1 2018/2019 by amendments to the terms and conditions of the convertible debentures. The holder of the convertible debentures has approved the amendments.On 24 January 2019, the board of directors resolved to amend the conditions of the convertible debentures regarding that the loan is due for payment on the 15-month anniversary of the date of registration at the Swedish Companies Registration Office of the resolution,

Fazer Yosa oat drinks contain the highest oat levels at the market

Fri, Jan 25, 2019 08:02 CET

Fazer Yosa continues its mission to conquer the Nordics with a range of new oat-based products. For the fast-moving consumer who wants a delicious healthy drink on-the-go, Fazer Yosa now offers two new oat-based drinks in convenient 2,5 dl package. To bring home, Fazer Yosa offers a delicious one litre oat-based coffee flavoured drink.Overall oat-based offerings in the markets has evolved and grown rapidly. Consumers have welcomed oat-based products as part of their daily diets. According to the studies, the healthy oat-based products are here to stay which is why we at Fazer Lifestyle

Kamux’s showroom network growing again in Finland: showroom no. 47 opening to Klaukkala in Nurmijärvi

Kamux Corporation Press Release, 25 January 2019 at 9:00 Kamux’s showroom network growing again in Finland: showroom no. 47 opening to Klaukkala in Nurmijärvi Kamux, a company specialising in used car sales, is continuing on a strong growth track. Kamux is expanding its operations by opening a new showroom in Klaukkala in Nurmijärvi in March 2019. Showroom network strengthens “The Klaukkala showroom will be a perfect addition to our current showroom network because it is located between the Helsinki Metropolitan Area and Hyvinkää showrooms. Klaukkala is both a

New Chairman of Resurs Holding in the autumn

The Chairman of the Board of Resurs Holding, Jan Samuelson, has declined re-election at the Annual General Meeting to be held in April 2019, but has agreed with the Nomination Committee to continue in his role of Chairman until the Extraordinary General Meeting that is usually held in the autumn.Jan Samuelson has served as Chairman of Resurs Holding since 2012 when Nordic Capital acquired the majority of the shares in the company. Resurs has since reported strong growth and the company is now four or five times larger in size.“These have been very exciting years in Resurs’s history. First

Year-end report January - December 2018

During the fourth quarter, the strategic plan continued to be implemented at a high pace and sales and profitability increased year-on-year. The Group’s sales increased 5.1 percent driven by the Byggmax segment. Profitability measured as EBITDA excluding non-recurring items increased to SEK 27.5 M, compared with SEK 22.1 M for the year-earlier period. Sales for the Byggmax segment increased 9.7 percent year-on-year, driven by strategic growth initiatives. In 2018, we opened 18 new Byggmax stores, 12 Garden concepts, and continued to develop our e-commerce. Byggmax’s sales were also

Notice of fourth quarter 2018 results and conference call

Luxembourg, 25 January 2019 – Millicom will announce its fourth quarter results for the period ending 31 December 2018, on 7 February 2019 at approximately 22:00 (Stockholm) / 21:00 (London) / 16:00 (Miami) via a press release. The company will host a conference call for the global financial community on 8 February 2019 at 14:00 (Stockholm) / 13:00 (London) / 08:00 (Miami). The conference call will be webcast at www.millicom.com Dial-in information: Please dial in 5-10 minutes before the scheduled start time to register your attendance. Dial-in numbers for the call are as

Nordic Nanovector - Private placement successfully completed

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia Oslo, Norway, 25 January 2019 Reference is made to the stock exchange release from Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company"), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics, published on 24 January 2019 regarding the contemplated private placement of new shares in the Company.

Fazer Yosa launches new oat-based innovation for cooking

The demand for more plant-based cooking products is increasing amongst the Nordic consumer. Fazer Lifestyle Foods is taking this demand serious, and is now entering the market with a completely new segment of oat innovations. Fazer Yosa is now offering new oat-based protein innovation for cooking, called Fazer Yosa Oat Block.The current Fazer Yosa assortment includes tasty oat-based products for multiple uses around the clock. With Fazer Yosa Oat Block, Fazer Lifestyle Foods enters the growing category of plant-based cooking products. The product can be used in cooking in the same occasions

Invitation to the presentation of Edgeware’s fourth quarter and year-end for report 2018

Edgeware's report for the fourth quarter and year-end report 2018 will be published at 07:30 CET on February 1A web-cast telephone conference will be held at 10:00 CET the same day, where CEO Karl Thedéen and CFO Annika Norin will present the report. The presentation will be followed by a Q&A session. The presentation will be held in English and can be followed on the web or over the phone. To participate in the conference call, call one of the following numbers: SE: +46850558350 UK: +443333009031 US: +16467224957 You can follow and listen to the presentation on the

Elekta to showcase precision radiation medicine for treating cancer at Arab Health Exhibition and Congress

Elekta’s cutting-edge hardware and software innovations are transforming cancer therapy and ushering radiation therapy into the age of personalized precision medicineDUBAI, United Arab Emirates, January 25, 2019 – At the Arab Health Exhibition and Congress, 28-31 January in Dubai, Elekta (EKTA-B.ST) will highlight how the company is collaborating with hospitals and clinicians in the Middle East and Africa to build better cancer programs for their patients. At booth #S1A30, Elekta will showcase the company’s innovative technologies for delivering precision radiation medicine, including

Proposals by CapMan's Shareholders' Nomination Board to the 2019 Annual General Meeting

CapMan Plc Stock Exchange Release 25 January 2019 at 08.30 EET Proposals by CapMan's Shareholders' Nomination Board to the 2019 Annual General Meeting Board Composition CapMan's Shareholders' Nomination Board has submitted its proposals to the 2019 Annual General Meeting to CapMan's Board of Directors. The Nomination Board makes its proposals unanimously. The Shareholders' Nomination Board proposes that the Board consists of six (6) members, the Chairman and the Deputy Chairman included, and that the following persons be elected to the Board of Directors for a term

Ericsson reports fourth quarter and full year results 2018